Protherics Plc - Report of Foreign Issuer (6-K)
24 July 2008 - 11:21PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
22 July 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into
English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under
the
Securities Exchange Act of 1934.
Yes
No
X
If “Yes” is marked, indicate below the
file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
.
The Registrant is furnishing a copy of its
announcements as reported to the Company Announcements Office of the London Stock
Exchange.
Protherics PLC
2008 Annual General Meeting Results
Lon
don, UK; Brentwood, TN, US: 22 July 2008
-
Protherics PLC (the
“Company”), the international biopharmaceutical company focused on critical
care and cancer, is pleased to announce that Resolutions 1 to 7 and 9 to 11 put forward at
the Annual General Meeting of the Company held earlier today were passed. Since Resolution
7 was passed, Resolution 8 was withdrawn.
The proxy figures for the Resolutions are set out below and will shortly be displayed on
the Company’s website at
www.protherics.com
.
Resolution Number (as noted on proxy
form)
|
Shares For
|
Shares Discretionary
|
Shares Against
|
Shares Marked As Votes Withheld/
Abstentions
|
Poll
Yes/No
|
1
|
To receive the
Financial
Statements for the year ended 31 March 2007
together with the reports of the Directors and Auditors.
|
227,968,493
|
616,122
|
349,378
|
1,776
|
No
|
2
|
To elect R B Soderstrom as a Director.
|
228,087,050
|
613,554
|
172,810
|
62,355
|
No
|
3
|
To reappoint KPMG Audit Plc as Auditors of the
Company.
|
228,114,010
|
624,117
|
190,689
|
6,953
|
No
|
4
|
To authorise the Directors to set the remuneration
of the Auditors.
|
228,147,226
|
618,045
|
163,724
|
6,774
|
No
|
5
|
To approve the Directors’ Remuneration
Report for the year ended 31 March 2008.
|
152,200,073
|
610,805
|
59,894,074
|
16,230,817
|
No
|
6
|
To authorise the Directors to allot shares
pursuant to Section 80 of the Companies Act 1985 (the
“Act”)
|
227,624,529
|
615,890
|
607,360
|
87,990
|
No
|
7
|
To authorise the Directors to disapply pre-emption
rights pursuant to Section 95 of the Act (10%).
|
220,212,918
|
627,390
|
3,747,064
|
4,348,397
|
No
|
8
|
To authorise the Directors to disapply pre-emption
rights pursuant to Section 95 of the Act (5%).
|
228,076,114
|
622,456
|
143,951
|
93,248
|
No
|
9
|
To receive and adopt the amended Articles of
Association.
|
228,004,502
|
639,725
|
189,939
|
101,603
|
No
|
10
|
To approve and adopt the Protherics PLC 2008
Savings-Related Share Option Scheme.
|
228,181,154
|
625,467
|
97,992
|
31,156
|
No
|
11
|
To authorise the Directors to make amendments to
the Protherics PLC 1996 unapproved Share Option Scheme
|
228,123,047
|
636,098
|
142,146
|
34,478
|
No
|
The full text of the resolutions together with the related Circular to Shareholders can be
viewed at:
The Document Viewing Facility
The Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS
| Ends |
F
or f
urther
i
nformation
please
contact
:
Protherics
|
|
Nick Staples,
Director of Corporate
Affairs
|
+44 (0) 7919 480510
|
Julie Vickers, Company Secretary
|
+44 (0)1928 518000
|
|
|
Financial Dynamics
– press
enquiries
|
|
London:
Ben
Atwell, Lara Mott
|
+44 (0) 20 7831 3113
|
New York:
John
Capodanno
|
+1 212 850 5600
|
Or visi
t
www.protherics.com
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
PROTHERICS PLC
|
|
|
|
|
|
|
|
Date: 22 July 2008
|
|
By:
|
|
/s/ Rolf Soderstrom
|
|
|
|
|
Rolf Soderstrom
|
|
|
|
|
Finance Director
|
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Oct 2023 to Oct 2024